Cargando…
N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin
N-methyl-2-pyridone-5-carboxamide (2PY, a major metabolite of nicotinamide, NAM) was recently identified as a uremic toxin. Recent interventional trials using NAM to treat high levels of phosphorus in end-stage renal disease have highlighted new potential uremic toxicities of 2PY. In the context of...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127135/ https://www.ncbi.nlm.nih.gov/pubmed/27854278 http://dx.doi.org/10.3390/toxins8110339 |
_version_ | 1782470218038116352 |
---|---|
author | Lenglet, Aurélie Liabeuf, Sophie Bodeau, Sandra Louvet, Loïc Mary, Aurélien Boullier, Agnès Lemaire-Hurtel, Anne Sophie Jonet, Alexia Sonnet, Pascal Kamel, Said Massy, Ziad A. |
author_facet | Lenglet, Aurélie Liabeuf, Sophie Bodeau, Sandra Louvet, Loïc Mary, Aurélien Boullier, Agnès Lemaire-Hurtel, Anne Sophie Jonet, Alexia Sonnet, Pascal Kamel, Said Massy, Ziad A. |
author_sort | Lenglet, Aurélie |
collection | PubMed |
description | N-methyl-2-pyridone-5-carboxamide (2PY, a major metabolite of nicotinamide, NAM) was recently identified as a uremic toxin. Recent interventional trials using NAM to treat high levels of phosphorus in end-stage renal disease have highlighted new potential uremic toxicities of 2PY. In the context of uremia, the accumulation of 2PY could be harmful—perhaps by inhibiting poly (ADP-ribose) polymerase-1 activity. Here, we review recently published data on 2PY’s metabolism and toxicological profile. |
format | Online Article Text |
id | pubmed-5127135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-51271352016-12-02 N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin Lenglet, Aurélie Liabeuf, Sophie Bodeau, Sandra Louvet, Loïc Mary, Aurélien Boullier, Agnès Lemaire-Hurtel, Anne Sophie Jonet, Alexia Sonnet, Pascal Kamel, Said Massy, Ziad A. Toxins (Basel) Review N-methyl-2-pyridone-5-carboxamide (2PY, a major metabolite of nicotinamide, NAM) was recently identified as a uremic toxin. Recent interventional trials using NAM to treat high levels of phosphorus in end-stage renal disease have highlighted new potential uremic toxicities of 2PY. In the context of uremia, the accumulation of 2PY could be harmful—perhaps by inhibiting poly (ADP-ribose) polymerase-1 activity. Here, we review recently published data on 2PY’s metabolism and toxicological profile. MDPI 2016-11-15 /pmc/articles/PMC5127135/ /pubmed/27854278 http://dx.doi.org/10.3390/toxins8110339 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lenglet, Aurélie Liabeuf, Sophie Bodeau, Sandra Louvet, Loïc Mary, Aurélien Boullier, Agnès Lemaire-Hurtel, Anne Sophie Jonet, Alexia Sonnet, Pascal Kamel, Said Massy, Ziad A. N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin |
title | N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin |
title_full | N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin |
title_fullStr | N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin |
title_full_unstemmed | N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin |
title_short | N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin |
title_sort | n-methyl-2-pyridone-5-carboxamide (2py)—major metabolite of nicotinamide: an update on an old uremic toxin |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127135/ https://www.ncbi.nlm.nih.gov/pubmed/27854278 http://dx.doi.org/10.3390/toxins8110339 |
work_keys_str_mv | AT lengletaurelie nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT liabeufsophie nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT bodeausandra nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT louvetloic nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT maryaurelien nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT boullieragnes nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT lemairehurtelannesophie nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT jonetalexia nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT sonnetpascal nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT kamelsaid nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin AT massyziada nmethyl2pyridone5carboxamide2pymajormetaboliteofnicotinamideanupdateonanolduremictoxin |